Robert B. Mondesi

Array ( [id] => 418671 [patent_doc_number] => 07276342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Xobesin agonists and antagonists for the treatment of metabolic disorders' [patent_app_type] => utility [patent_app_number] => 10/485233 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11851 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276342.pdf [firstpage_image] =>[orig_patent_app_number] => 10485233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275689 [patent_doc_number] => 20040235140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Expression system' [patent_app_type] => new [patent_app_number] => 10/483150 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3357 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235140.pdf [firstpage_image] =>[orig_patent_app_number] => 10483150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7365267 [patent_doc_number] => 20040005690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Modified CBD/RGD recombinant attachment factor for improving cell-attachment efficiency and the manufacturing method thereof' [patent_app_type] => new [patent_app_number] => 10/180120 [patent_app_country] => US [patent_app_date] => 2002-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3496 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005690.pdf [firstpage_image] =>[orig_patent_app_number] => 10180120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 737999 [patent_doc_number] => 07034132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Therapeutic polypeptides, nucleic acids encoding same, and methods of use' [patent_app_type] => utility [patent_app_number] => 10/162335 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96627 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034132.pdf [firstpage_image] =>[orig_patent_app_number] => 10162335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440191 [patent_doc_number] => 20040185428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof' [patent_app_type] => new [patent_app_number] => 10/476904 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4981 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185428.pdf [firstpage_image] =>[orig_patent_app_number] => 10476904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923115 [patent_doc_number] => 07319087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Antimicrobial polypeptide from Aspergillus niger' [patent_app_type] => utility [patent_app_number] => 10/474647 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 13083 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319087.pdf [firstpage_image] =>[orig_patent_app_number] => 10474647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725499 [patent_doc_number] => 20030207811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Method of treating retinopathy of prematurity using somatostatin analogs' [patent_app_type] => new [patent_app_number] => 10/138554 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6587 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207811.pdf [firstpage_image] =>[orig_patent_app_number] => 10138554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 978826 [patent_doc_number] => 06929929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins' [patent_app_type] => utility [patent_app_number] => 10/133534 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5959 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/929/06929929.pdf [firstpage_image] =>[orig_patent_app_number] => 10133534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 651089 [patent_doc_number] => 07112666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-26 [patent_title] => 'Von Willebrand Factor (Vwf)-cleaving protease' [patent_app_type] => utility [patent_app_number] => 10/475538 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 15619 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112666.pdf [firstpage_image] =>[orig_patent_app_number] => 10475538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206084 [patent_doc_number] => 20050043227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension' [patent_app_type] => utility [patent_app_number] => 10/475403 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19666 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043227.pdf [firstpage_image] =>[orig_patent_app_number] => 10475403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405627 [patent_doc_number] => 20040175778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations' [patent_app_type] => new [patent_app_number] => 10/473364 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7166 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175778.pdf [firstpage_image] =>[orig_patent_app_number] => 10473364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788283 [patent_doc_number] => 20020160934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for larval viability and uses thereof' [patent_app_type] => new [patent_app_number] => 10/108605 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13175 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160934.pdf [firstpage_image] =>[orig_patent_app_number] => 10108605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7471408 [patent_doc_number] => 20040096953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing composition, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same,' [patent_app_type] => new [patent_app_number] => 10/472237 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7488 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096953.pdf [firstpage_image] =>[orig_patent_app_number] => 10472237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798002 [patent_doc_number] => 07427589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Use of cytokine inhibitors' [patent_app_type] => utility [patent_app_number] => 10/092919 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5182 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427589.pdf [firstpage_image] =>[orig_patent_app_number] => 10092919 [rel_patent_id] =>[rel_patent_doc_number] =>)